CLINICAL_TRIALS
trial_result
· 2011-11-11
Clinical Trial Update: Dose-Range Finding Study for MK0893 (0893-008) [Phase 2]
Summary
This Phase 2 dose-range finding trial of MK0893 (0893-008) in Type 2 diabetes was terminated. Results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: TERMINATED | Results posted: 2011-11-11